Nation Alzheimer’s patients ‘devastated’ at Medicare limits on drug critics say needs more testing February 18, 2022 Ken Alltucker, USA TODAY Comments Off on Alzheimer’s patients ‘devastated’ at Medicare limits on drug critics say needs more testing Biogen, other drug companies are challenging Medicare's preliminary decision to pay for Aduhelm and other Alzheimer's drugs only in clinical trials.